| Document |
Document Title |
|
JPH01149730A |
PURPOSE:To obtain the title inhibitor which is useful in treatment for retrovirus infection, especially AIDS, with excellent combination of safety and efficacy, by containing monosaccharide or disaccharide derivative as an active ingredi...
|
|
JPH01100187A |
NEW MATERIAL: A metal-contg. oligosaccharide-polysulfate compd., contg. the metal ions of the elements of atomic numbers 21 to 29, 42, 44 or 56 to 83. EXAMPLE: A sucrose-polysulfate-gadolinium compd. USE: A diagnostic agent for NMR- and ...
|
|
JPS6472982A |
PURPOSE: To make it possible to lower the sourness of fruits and fruit vegetables by adding glucose phosphate to a quality improving agent for the fruits and fruit vegetables. CONSTITUTION: This quality improving agent is the quality imp...
|
|
JPS648639B2 |
|
|
JPS63229057A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS63218691A |
NEW MATERIAL:A compound shown by formula I (Me is methyl). EXAMPLE: Methyl O-( 2-deoxy-2-sulfamido-6-O-sulfo-α-D-glucopyranosyl-(1→4)-O-
(β-D-glucopyranosyluronic acid )-( 1→4 )-O-( 2-deoxy-2-sulfamido-3,6-di-O-sulfo-α- D-glu-cop...
|
|
JPS63198630A |
PURPOSE: To obtain a lipid metabolism improver having immediate effects free from side effects, containing a calcium hexose phosphate as an active ingredient. CONSTITUTION: A calcium hexose phosphate (e.g. calcium glucose-1-phosphate) an...
|
|
JPS6328411B2 |
An expectorant capable of acting on the rheological properties of sputum and capable of directly promoting the ciliary motion. The expectorant contains N-acetyineuramin- ic acid or a pharmaceutically active salt thereof.
|
|
JPS6391394A |
Compounds of formula I wherein R1 represents a sugar residue X and Y are the same or different and stand for oxygen or the imino group, and R2 and R3 are the same or different and represent an optionally substituted acyl group, which pro...
|
|
JPS6388194A |
The saccharide phosphates have the general formulae (I) and (II) in which R<1>, R<2> and R<3> have the meaning indicated in the description.
|
|
JPS6366192A |
The oligosaccharides of the invention are composed essentially of chains: possessing a specific affinity for the anionic and cationic cell growth factor which recognize herparin, comprising at least one sequence of 5 residues matching th...
|
|
JPS62258395A |
NEW MATERIAL:A C-6 position-O-replaced substance of 2-deoxy-4-O-phos phoryl-3-O-tetradecanoyl-2-{[(R type, S type and racemic type)-3-O-tetra decanoyl]-tetradecanoylamino}-D-glucopyranose compound shown by formula I [X is 6-O-succinoylam...
|
|
JPS62228020A |
Fructose-1,6-diphosphate (FDP) is used to achieve a protective action towards the toxicity caused to the metabolism and the cellular integrity by the prolonged administration of anthracyclinic antitumour drugs. The invention relates as w...
|
|
JPS62221694A |
NEW MATERIAL:The compound of formula I. USE: An immunoenhancer having low side effect and obtained by bonding sialic acid to a phosphoryl-glucosamine derivative which is an active component of lipid A. PREPARATION: N-acetylneuraminic aci...
|
|
JPS62205096A |
NEW MATERIAL:A compound expressed by formula I (R1 and R2 represent 11W13C alkyl; R3 represents acyl). EXAMPLE: 2-[(R)-3'-Dodecanoyloxytetradodecanoyl]amino-2-deoxy-3-[(R)-
3'-te tradodecanoyloxytetradodecanoyl ]oxy-4-phosphono-6-[(4,5,7...
|
|
JPS62190127A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS62145051A |
Butyramide derivatives of the formula I wherein the variables A, X, Y, R and R0 are as defined in the specification, possess valuable pharmacological properties, especially as analgesics and antihypertensives. They are prepared by method...
|
|
JPS62129293A |
NEW MATERIAL:A C-6 position-O-substituted substance of 2-deoxy-4-O- phosphoryl-3-O-tetradecanoyl-2-{[(racemic type or R type and S type)-3-O- tetradecanoyl]-tetradecanoylamino}-D-glucopyranose compound shown by the formula [X is succinic...
|
|
JPS62129292A |
NEW MATERIAL:A 2-deoxy-2-substituted amino-3-O-substituted-4-O-phosphoryl-D- glucopyranose shown by formula [R1 is (3-O-dodecanoyl)-tetradecanoyl or (3-O- hexadecanoyl)-tetradecanoyl when R2 is tetradecanoyl and when one of R1 and R2 are...
|
|
JPS6236394A |
Novel esterified oligosaccharides including at least one esterified disaccharide unit consisting of a uronic acid residue and a hexosamine residue can be topically applied to mammalian skin to improve the appearance of hair and other ben...
|
|
JPS6227402A |
A glycosaminoglycane used in the form of a salt soluble in an organic medium is subjected to the action of a given sulphating agent.
|
|
JPS624297A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS61251694A |
Zinc fructose 1.6-diphosphate of the formula: wherein n = 0 to 4.
|
|
JPS6141502B2 |
Disclosed are novel polyhydric alcohol partial esters of polycarboxylic acids from Diels-Alder adducts of maleic anhydride and a straight chain unsaturated carboxylic acid having ten to twenty-five carbon atoms. The partial esters can be...
|
|
JPS61501919A |
2,3-Diamino-2,3-dideoxyhexose derivatives of the formula DOLLAR F1 in which R1 is hydrogen, a lower alkyl group or an aralkyl group, and R2 and R3 are identical or different and each is an optionally substituted acyl group.
|
|
JPS61129189A |
PURPOSE: A mixture containing a specific organophosphoric acid ester, its salts, orthophosphoric acid and its salts is subjected to dialysis to enable high- efficiency purification of the title phosphoric acid ester through a simple proc...
|
|
JPS6125038B2 |
A process for converting aldoses or derivatives thereof into ketoses or derivatives thereof which takes place in the presence of oxyanions or mixed complex oxyanions of germanium or tin which form stronger complexes with the ketoses or d...
|
|
JPS6115894A |
NEW MATERIAL:The compound of formula I. USE: Blood coagulation inhibitor, antithrombotic. PREPARATION: The compound of formula II is subjected to deacylation, the product is converted into a sulfate and treated with an Na+ type ion-excha...
|
|
JPS60259191A |
A strain of actinomycete, NRRL 15758, is capable of producing the CL-1724 complex of compounds under conditions of aerobic fermentation in the presence of assimilable sources of carbon and nitrogen. The compound CL-1724B-2 exhibits antim...
|
|
JPS60237093A |
NEW MATERIAL:The phosphosaccharide compound of formula I (R1WR5 are H, alkanoyl or aralkyl; A is H, OH, O-alkyl, O-aryl or O-aralkyl). EXAMPLE: 5-Deoxy-5-C-(hydroxyphosphinyl)-α,β-D-glucopyranose. USE: Reagent for the research of bioch...
|
|
JPS60228495A |
Compounds of formula (1) wherein n = 1 or 2 are prepared by reacting L-carnitine and alpha -glucose-1-phosphoric acid in aqueous solution, and subsequently precipitating with organic solvents. Compounds I, in form of pharmaceutical compo...
|
|
JPS60161994A |
A process for the purification and isolation of fructose-2,6-diphosphate produced by cyclization of fructose-1,6-diphosphate and alkaline hydrolysis involves two chromatography steps, treatment with a cationic exchange resin and lyophili...
|
|
JPS60161995A |
PURPOSE: To improve remarkably the solubility of p-nitrophenyl N-acetyl-β-D- glucosaminide, by pulverizing physically the above-mentioned compound, and passing the pulverized compound through a screen of specific mesh size. CONSTITUTION...
|
|
JPS60156697A |
The process according to the invention provides, for the purification of FDPH4-containing solutions, for a double chromatography combined with the molecular filtration. There are thus obtained concentrated and highly pure solutions conta...
|
|
JPS60501259A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS6069087A |
The invention relates to phosphorylating agents containing at least one protected hydroxyl group and at least one leaving group. According to the invention, a methylsulphonylethyl group (Mse) is used as the hydroxyl protecting group. Typ...
|
|
JPS6036492A |
Compounds of formula: in which n is 2 to 9, U is a chain unit of the uronic acid type, G1 and G2 are chain units of respective formulae: R, R1 and R2 are H or SO3<->, M<+>, R' and R'' are SO3 M<+> or CH3-CO-, -O- is an oxygen bridge and ...
|
|
JPS6025925A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS6025995A |
The products consist of complexes made up of ATIII and oligosaccharides which have a high anti-Xa specific activity.
|
|
JPS59222499A |
Compounds (9) and (10) have valuable antibiotic activity. A method of treating microbial diseases using them is described as well.
|
|
JPS5989698A |
NEW MATERIAL:A compound of formula I (R1WR3 are OH, alkoxyl, alkanoylamino, etc.; A is lower alkylene; R4 is alkylammonio, cyclic ammonio or cyclic amino; R6 is oxide anion or OH) and a salt thereof. EXAMPLE: Methyl-2-O-methyl-3-O-octade...
|
|
JPS5921597B2 |
Strains of Actinoplanes produce an antibiotic substance upon aerobic cultivation. The antibiotic is soluble in water with a pronounced band in the UV absorption spectrum at 267 nm. Methods for preparing and using the antibiotic, both the...
|
|
JPS5942394A |
NEW MATERIAL:The compound of formula I [R1 is alkyl(thio), alkoxy, or alkylsulfonyl; R2 is H, OH, alkoxy, lower alkanoyloxy, etc.; R3 is (protected) OH; R4 is lower alkoxy or lower cycloaliphatic-oxy substituted with ≥2 (protected) OH ...
|
|
JPS5936693A |
PURPOSE: To obtain the titled compound useful as an intermediate for synthesizing a saccharide phosphoric ester, etc., having improved stability, reactivity, handleability, etc., industrially advantageously, by treating a protected sacch...
|
|
JPS5936692A |
PURPOSE: To obtain the titled compound, a constitutional unit of lipopolysaccharide existing in the cell wall of Gram-negative bacterium, useful as a drug and agricultural chemical, more easily by synthesis, by reacting a protected sacch...
|
|
JPS5921617A |
The invention relates to a fructose 1,6-diphosphate product for intravenous use with antiallergic effect for the treatment and prevention of anaphylactic manifestations, acute attacks of asthma, angioneurotic oedema, bronchospasms, urtic...
|
|
JPS591499A |
The invention relates to (a) new Amadori rearrangement products derived from phosphatidyl-ethanolamine (i) and a reducing sugar (ii), (b) a process for producing said products by allowing (i) to react with (ii) under substantially moistu...
|
|
JPS58208294A |
NEW MATERIAL:A complex of a saccharide polysulfate ester with a high basic aluminum polychloride of Al2+n(OH)3nCl6(4
|
|
JPS58126898A |
PURPOSE: To obtain the titled salt having high purity and useful as an antiulcer agent, easily, by reacting a sucrose polysulfate with aluminum isopropoxide. CONSTITUTION: The objective salt can be prepared by reacting aluminum isopropox...
|
|
JPS58118598A |
Poly-cation salts of bis-(or tris-) [polyhexaose-thio (or sulfinyl, or sulfonyl)]-arylene sulfate derivatives, useful as modulators of the complement system, the intermediates thereof and the process of making such intermediates and end ...
|
